Safety profile of parenteral meglumine antimoniate (Glucantime®) in infants treated for cutaneous leishmaniasis

被引：0
|
作者：
Frikha, Fatma [1 ]
Boudaya, Sonia [1 ]
Bahloul, Emna [1 ]
Amouri, Meriem [1 ]
Turki, Hamida [1 ]
机构：
[1] Hop Hedi Chaker, Serv Dermatol Venereol, Ave Ain, Sfax 3089, Tunisia
来源：
THERAPIE | 2020年 / 75卷 / 03期
关键词：
Cutaneous leishmaniasis; Glucantime; Meglumine antimoniate; Side effects; Infant; Children; HIGH-FREQUENCY; CHILDREN; PHARMACOKINETICS;
D O I：
10.1016/j.therap.2019.05.001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：314 / 316
页数：4
相关论文
共 50 条
  • [11] Intralesional meglumine antimoniate in the treatment of cutaneous leishmaniasis
    Heddle, Georgina
    De Rosa, Nicholas
    Tran, Alain
    [J]. AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2023, 64 : 61 - 61
  • [12] Pharmacometabolomics of Meglumine Antimoniate in Patients With Cutaneous Leishmaniasis
    Alejandro Vargas, Deninson
    Dario Prieto, Miguel
    Jose Martinez-Valencia, Alvaro
    Cossio, Alexandra
    Burgess, Karl E. V.
    Burchmore, Richard J. S.
    Adelaida Gomez, Maria
    [J]. FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [13] Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis
    Salmanpour, R
    Handjani, F
    Nouhpisheh, MK
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2001, 12 (03) : 159 - 162
  • [14] Localized leishmaniasis treated with intralesional meglumine antimoniate
    Villela-Segura, Uriel
    Proy-Trujillo, Hector
    Ilizaliturri-Flores, Ixtabay
    Leal-Ascencio, Victor Javier
    Eljure-Lopez, Nixma
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2020, 18 (09): : 1025 - 1027
  • [15] Therapeutic Potential of Green Synthesized Copper Nanoparticles Alone or Combined with Meglumine Antimoniate (Glucantime(R)) in Cutaneous Leishmaniasis
    Albalawi, Aishah E.
    Abdel-Shafy, Sobhy
    Khalaf, Amal Khudair
    Alanazi, Abdullah D.
    Baharvand, Parastoo
    Ebrahimi, Katrin
    Mahmoudvand, Hossein
    [J]. NANOMATERIALS, 2021, 11 (04)
  • [16] Comparison of meglumine antimoniate and pentamidine for Peruvian cutaneous leishmaniasis
    Andersen, EM
    Cruz-Saldarriaga, M
    Llanos-Cuentas, A
    Luz-Cjuno, M
    Echevarria, J
    Miranda-Verastegui, C
    Colina, O
    Berman, JD
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 72 (02): : 133 - 137
  • [17] Standardization of intralesional meglumine antimoniate treatment for cutaneous leishmaniasis
    de Oliveira Duque, Maria Cristina
    Ferreira e Vasconcellos, Erica de Camargo
    Fernandes Pimentel, Maria Ines
    Lyra, Marcelo Rosandiski
    Bedoya Pacheco, Sandro Javier
    de Almeida Marzochi, Mauro Celio
    Valete Rosalino, Claudia Maria
    Schubach, Armando de Oliveira
    [J]. REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL, 2016, 49 (06) : 774 - 776
  • [18] Intralesional ciprofloxacin for cutaneous leishmaniasis: Comparison with meglumine antimoniate
    Arshad, Abdul Rehman
    Arshad, Abdullah
    [J]. PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2011, 27 (03) : 566 - 568
  • [19] VISCERAL LEISHMANIASIS DURING PREGNANCY TREATED WITH MEGLUMINE ANTIMONIATE
    UTILI, R
    RAMBALDI, A
    TRIPODI, MF
    ANDREANA, A
    [J]. INFECTION, 1995, 23 (03) : 182 - 183
  • [20] Allergic reactions to meglumine antimoniate while treating cutaneous leishmaniasis
    Brasileiro, A.
    Martin-Ezquerra, G.
    Garcia-Martinez, P.
    Pujol, R. M.
    Gimenez-Arnau, A. M.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 (01) : E59 - E60
12345